HB
INSIDER · ELVN · Enliven Therapeutics, Inc. · CHIEF FINANCIAL OFFICER
Hohl Benjamin
Every open-market transaction filed under this name, Sep 17 to Sep 17.
Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$303K
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 17 | ELVN | Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sell | 289 | $51.49 | $15K | — |
| Sep 17 | ELVN | Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sell | 2,194 | $50.72 | $111K | — |
| Sep 17 | ELVN | Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sell | 3,535 | $50.03 | $177K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.